Are GLP-1s peptides?
Common GLP-1 receptor agonists are peptide-based medicines designed to act on defined metabolic pathways. Tirzepatide acts on both GIP and GLP-1 receptors. These medicines have specific labels, doses, indications, contraindications and monitoring considerations.
The phrase peptide therapy can also refer to products discussed for recovery, hormone signaling, longevity-oriented goals, immune function or other uses. That broad label does not establish that two products work the same way or have comparable evidence.
The practical differences
Use the exact product to compare the pathways.
- Purpose: GLP-1 medicines have defined approved indications; other peptides may be considered for different goals.
- Evidence: approval and clinical evidence vary product by product.
- Access: a prescription drug, patient-specific compounded preparation and research-use product follow different routes.
- Cost: brand, compounded and preferred-partner prices are not interchangeable.
- Coverage: insurance formulary rules and Gabriel Care eligibility are separate decisions.
What to know about compounded GLP-1 products
Compounded drugs are not FDA approved. FDA has specifically warned telehealth companies against describing compounded GLP-1 products as generic, the same as an FDA-approved drug, clinically proven to produce the same result, or sourced from an FDA-approved pharmacy.
A compounded product may serve an individual patient need in circumstances allowed by law, but its source, formulation and clinical rationale should be clear. Gabriel does not make equivalence claims or direct the clinical decision.
How Gabriel Care approaches coverage
Gabriel Care provides 100% reimbursement of eligible costs through preferred partner brands. Depending on the exact pathway, eligible expenses may include prescription or lawfully compounded peptide-based care and verified preferred-partner peptide products.
Gabriel is a private health membership, not a peptide or GLP-1 company. It helps members navigate coverage and reimbursement while independent licensed clinicians and pharmacies remain responsible for medical care and dispensing.
Common questions
What people ask next.
Are GLP-1s peptides?
GLP-1 medicines are peptide-based receptor agonists. They belong within the broader peptide category, but the term peptide therapy includes many products that are not GLP-1 medicines.
Are peptides and GLP-1s the same thing?
No. GLP-1s are a specific drug class, while peptides are a much broader family of molecules and products with different uses, evidence and regulatory status.
What is the difference between peptides and GLP-1s for weight loss?
Approved GLP-1 or dual-receptor medicines have specific metabolic indications and prescribing information. Other products marketed as weight-loss peptides may have different or limited evidence and should not be treated as equivalent.
Does insurance cover GLP-1 peptides?
Some plans cover a specific FDA-approved medicine for a covered diagnosis, often with formulary and prior-authorization rules. Coverage varies by drug, indication and plan.
Does Gabriel Care cover GLP-1s and other peptides?
Gabriel Care may reimburse eligible prescription, lawfully compounded and preferred-partner peptide expenses under current terms. Gabriel provides 100% reimbursement of eligible costs through preferred partner brands.